Dabigatran etexilate in a vitamin‐K antagonist non responder patient during Heartware HVAD support. Issue 2 (17th January 2017)

• Record Type: Journal Article
• Authors: Baronetto, Andrea; Centofanti, Paolo; Attisani, Matteo; Boffini, Massimo; Ricci, Davide; Simonato, Erika; Rinaldi, Mauro
• Is Part Of: Journal of cardiac surgery. Volume 32:Issue 2(2017)
• Page Start: 166
• Page End: 167
• Publication Date: 2017-01-17
• Subjects: dabigatran etexilate -- heart failure -- ventricular assist device; Heart -- Surgery -- Periodicals; 617.412005
• DOI: 10.1111/jocs.13097
• Languages: English
• ISSNs: 0886-0440

Abstract

Abstract: We report a case of a patient supported with a HeartWare left ventricular assist device for idiopathic cardiomyopathy who was resistance to vitamin‐K antagonists three months after implantation. The patient initially started low‐molecular‐weight heparin therapy and then, after the onset of an ischemic stroke, switched to dabigatran etexilate (DE). The patient had progressive recovery of cardiac function for which the device was explanted. No thrombotic or bleeding events occurred during DE therapy.